A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made “exciting,” patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors.
Hospital Complications Rise After Private Equity Buyout
After private equity acquisition, medical centers had an increase in hospital-acquired adverse events, despite a shift to a lower-risk case mix, a study of Medicare
December 27, 2023